Livro “Mastologia para o Estudante de Medicina”
Autor(a): Rafaela de Souza Furtado
Co-autor(a): Geovanna Cota Caetano
Orientador(a): Angélica Nogueira Rodrigues
Sessão VI - Oncologia e Radioterapia Mamária - MASTOLOGIA PARA ESTUDANTES DE MEDICINA
| Artigo | Autor(es) | Referência |
|---|---|---|
| American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. | Visvanathan Kala, Chlebowski Rowan T, Hurley Patricia, Col Nananda F, Ropka Mary, Collyar Deborah, Morrow Monica, Runowicz Carolyn, Pritchard Kathleen I, Hagerty Karen, Arun Banu, Garber Judy, Vogel Victor G, Wade James L, Brown Powel, Cuzick Jack, Kramer Barnett S, Lippman Scott M, | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jul; 27(Jul):3235-58. doi: 10.1200/JCO.2008.20.5179. pii: . |
| Breast cancer prevention in high-risk women. | Thorat Mangesh A, Balasubramanian Rajeshkumar | Best practice & research. Clinical obstetrics & gynaecology. 2020 May; 65(May):18-31. doi: 10.1016/j.bpobgyn.2019.11.006. pii: S1521-6934(19)30170-1. |
| Moduladores seletivos do receptor estrogênico: novas moléculas e aplicações práticas / Selective estrogen receptor modulators: new molecules and practical uses | Ferreira, Márcia Cristina França; Souza, Karla Zanolla Dias de; Dummont, Joana Sara Fonseca; Barra, Alexandre Almeida; Rocha, Ana Luiza Lunardi. | Femina;39(9), set. 2011. ilus, tab. |
| Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia. | DeCensi Andrea, Puntoni Matteo, Guerrieri-Gonzaga Aliana, Caviglia Silvia, Avino Franca, Cortesi Laura, Taverniti Cristiana, Pacquola Maria Grazia, Falcini Fabio, Gulisano Marcella, Digennaro Maria, Cariello Anna, Cagossi Katia, Pinotti Graziella, Lazzeroni Matteo, Serrano Davide, Branchi Daniela, Campora Sara, Petrera Marilena, Buttiron Webber Tania, Boni Luca, Bonanni Bernardo | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 07; 37(07):1629-1637. doi: 10.1200/JCO.18.01779. pii: . |
| Risk-reducing medications for primary breast cancer: a network meta-analysis. | Mocellin Simone, Goodwin Annabel, Pasquali Sandro | The Cochrane database of systematic reviews. 2019 Apr; 4(Apr):CD012191. doi: 10.1002/14651858.CD012191.pub2. pii: . |
| Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention. | Vogel Victor G | Current drug targets. 2011 Dec; 12(Dec):1874-87. |
| Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. | Visvanathan Kala, Fabian Carol J, Bantug Elissa, Brewster Abenaa M, Davidson Nancy E, DeCensi Andrea, Floyd Justin D, Garber Judy E, Hofstatter Erin W, Khan Seema A, Katapodi Maria C, Pruthi Sandhya, Raab Rachal, Runowicz Carolyn D, Somerfield Mark R | Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 11; 37(11):3152-3165. doi: 10.1200/JCO.19.01472. pii: . |
| Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial. | Cuzick Jack, Sestak Ivana, Forbes John F, Dowsett Mitch, Cawthorn Simon, Mansel Robert E, Loibl Sibylle, Bonanni Bernardo, Evans D Gareth, Howell Anthony, | Lancet (London, England). 2020 01; 395(01):117-122. doi: 10.1016/S0140-6736(19)32955-1. pii: S0140-6736(19)32955-1. |
| Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. | Gail M H, Costantino J P, Bryant J, Croyle R, Freedman L, Helzlsouer K, Vogel V | Journal of the National Cancer Institute. 1999 Nov; 91(Nov):1829-46. |